Clinical Trial

Bronchoscopic Cryoablation Combined With Chemo-Immunotherapy in NSCLC With Central Airway Obstruction

Name: Bronchoscopic Cryoablation Combined With Chemo-Immunotherapy in NSCLC With Central Airway Obstruction — clinical trial record (NCT06604351)
Creator: DataLookout
License: https://creativecommons.org/licenses/by/4.0/

Study acronym: Example

Not Yet Recruiting Phase 2

View on ClinicalTrials.gov →

Summary

This study aimed to evaluate the efficacy and safety of bronchoscopic cryoablation combined with sintilimab plus platinum-based chemotherapy as First-line Treatment for locally advanced or metastatic NSCLC with central airway obstruction.

Trial Details

NCT Number	NCT06604351
Lead Sponsor	Hunan Province Tumor Hospital
Conditions	Non-Small Cell Lung Cancer
Enrollment	39 participants
Start Date	2024-09-15
Primary Completion	2027-10-31 (estimated)
Study Completion	2029-05-31 (estimated)
Updated on ClinicalTrials.gov	2024-09-19